Hana Pharm Co Ltd (293480) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.005x

Based on the latest financial reports, Hana Pharm Co Ltd (293480) has a cash flow conversion efficiency ratio of -0.005x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-1.41 Billion ≈ $-958.88K USD) by net assets (₩306.17 Billion ≈ $207.49 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Hana Pharm Co Ltd - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Hana Pharm Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 293480 liabilities breakdown for a breakdown of total debt and financial obligations.

Hana Pharm Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hana Pharm Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Siam Pan Group PCL BK:SPG	0.014x
TuHURA Biosciences Inc NASDAQ:HURA	-0.265x
ELK-Desa Resources Bhd KLSE:5228	0.025x
Molson Coors Beverage Company NYSE:TAP-A	0.051x
Zeotech Ltd AU:ZEO	-0.230x
Action SA WAR:ACT	-0.060x
Sun Yad Construction Co Ltd TW:1316	-0.001x
Turker Proje Gayrimenkul Ve Yatirim Gelistirme AS IS:TURGG	-0.003x

Annual Cash Flow Conversion Efficiency for Hana Pharm Co Ltd (2016–2024)

The table below shows the annual cash flow conversion efficiency of Hana Pharm Co Ltd from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see 293480 market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩309.18 Billion ≈ $209.52 Million	₩25.30 Billion ≈ $17.14 Million	0.082x	+23.60%
2023-12-31	₩277.98 Billion ≈ $188.39 Million	₩18.40 Billion ≈ $12.47 Million	0.066x	-42.46%
2022-12-31	₩268.40 Billion ≈ $181.89 Million	₩30.88 Billion ≈ $20.93 Million	0.115x	+12.98%
2021-12-31	₩251.90 Billion ≈ $170.71 Million	₩25.66 Billion ≈ $17.39 Million	0.102x	+51.91%
2020-12-31	₩232.38 Billion ≈ $157.48 Million	₩15.58 Billion ≈ $10.56 Million	0.067x	-53.43%
2019-12-31	₩220.33 Billion ≈ $149.32 Million	₩31.72 Billion ≈ $21.49 Million	0.144x	+7.17%
2018-12-31	₩205.39 Billion ≈ $139.19 Million	₩27.59 Billion ≈ $18.70 Million	0.134x	-56.98%
2017-12-31	₩81.30 Billion ≈ $55.09 Million	₩25.38 Billion ≈ $17.20 Million	0.312x	+38.97%
2016-12-31	₩55.48 Billion ≈ $37.60 Million	₩12.46 Billion ≈ $8.45 Million	0.225x	--

About Hana Pharm Co Ltd

KO:293480 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$115.01 Million

₩169.71 Billion KRW

Market Cap Rank

#18657 Global

#964 in Korea

Share Price

₩9810.00

Change (1 day)

-1.11%

52-Week Range

₩9090.00 - ₩12430.00

All Time High

₩26028.86